3. Dr. Jo Viney: Co-Founder, President and CSO of Pandion Therapeutics

episode

Biotech 2050 Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-29-2026 7AM EDT 4 min · 29 Sep 2026 · NPR News Now

7AM ET 09/29/2026 Newscast 3 min · 29 Sep 2026 · Fox News Hourly Update

Federal boost for Navitas 6 min · 29 Sep 2026 · Wall Street Breakfast

1031: Tokenomics: Why Your Agentic AI Bill Is Exploding (and How to Fix It), with Tyler Cox and Ish Shah 1h 14m · 29 Sep 2026 · Super Data Science: ML & AI Podcast with Jon Krohn

Being a Real Housewife with Erin Lichy 46 min · 29 Sep 2026 · Disgraceful with Grace O'Malley

1606 - Josh Finally Got his Wife to Hotwife for Him 56 min · 29 Sep 2026 · Strictly Anonymous Confessions

Report any issue

Source

Recorded29 Oct 2019

Publisherfeeds.soundcloud.com ↗

Handlerec:2867055

Show notes

Dr. Jo Viney is an entrepreneurial scientist and experienced biotech executive. A self-described “drug-hunter”, she has successfully advanced a number of programs into the clinic. She is Co-Founder, President and CSO of Pandion Therapeutics, a startup company in Cambridge, MA focused on developing new therapies for treating autoimmune and inflammatory diseases. On this episode of Biotech2050, Jo talked about her journey to the biotech industry and how she came to founding Pandion Therapeutics, successfully bringing a drug to market, women in leadership, and the importance of diversity in biotech.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in